The role of intraprostatic inflammation in the acute urinary retention
- PMID: 21448402
- PMCID: PMC3063463
The role of intraprostatic inflammation in the acute urinary retention
Abstract
Objectives: Almost 20% of patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) might also have symptoms of prostatitis. But, the interrelationship between BPH and prostatic inflammation, and how one can influence the other, is under controversy. The aim of our study was to determine the incidence of prostatic inflammation in BPH patients presented with acute urinary retention (AUR).
Methods: This crosssectional study was conducted in a hospital at Guilan, the northern province of Iran. A total of 280 patients undergoing transurethral resection of the prostate (TURP) or open prostatectomy from 1999 to 2002 were enrolled. Histopathologic samples of prostate were examined for existence of acute and/or chronic intraprostatic inflammation (ACI).
Results: Overall, 150 (536%) of patients undertook surgery for AUR and 130 (464%) for LUTS. Among them, 130 patients (46.4%) showed ACI in the pathologic examinations whereas 150 patients (53.6%) did not. The patients with AUR were significantly older than those with LUTS. ACI was significantly associated with AUR. The mean prostate weight was significantly higher in AUR group compared the LUTS group. Those patients who showed ACI according to pathologic examinations had heavier prostates than those who did not. The association of ACI and AUR should be considered in secondary prevention for BPH patients.
Conclusions: ACI may increase the degrees of urinary obstruction and AUR.
Keywords: Acute urinary retention; Benign prostatic hyperplasia; Inflammation.
Conflict of interest statement
Similar articles
-
Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?BJU Int. 2007 Aug;100(2):327-31. doi: 10.1111/j.1464-410X.2007.06910.x. BJU Int. 2007. PMID: 17617139
-
Retrospective Assessment of Post-Transurethral Resection of the Prostate Complications in Benign Prostatic Hyperplasia Patients: Impact of Acute Urinary Retention.Cureus. 2024 Oct 23;16(10):e72223. doi: 10.7759/cureus.72223. eCollection 2024 Oct. Cureus. 2024. PMID: 39583458 Free PMC article.
-
Do the medical treatment reduces the rate of surgical treatment in suspected cases of chronic prostatitis before prostatectomy?Eur Rev Med Pharmacol Sci. 2013 Jan;17(1):119-22. Eur Rev Med Pharmacol Sci. 2013. PMID: 23329532
-
Do alpha-blockers prevent the occurrence of acute urinary retention?Eur Urol. 2001 Mar;39 Suppl 6:13-8. doi: 10.1159/000052594. Eur Urol. 2001. PMID: 11306896 Review.
-
The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review.Aging Male. 2020 Dec;23(5):1620-1626. doi: 10.1080/13685538.2021.1901273. Epub 2021 Apr 5. Aging Male. 2020. PMID: 33818292 Review.
Cited by
-
Therapeutic efficacy of Cernilton in benign prostatic hyperplasia patients with histological prostatitis after transurethral resection of the prostate.Int J Clin Exp Med. 2015 Jul 15;8(7):11268-75. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26379934 Free PMC article.
-
Comparison of Serum Gamma Glutamyl Transferase Levels between Prostate Cancer Patients and Their Healthy Peers.Iran J Public Health. 2023 Jul;52(7):1487-1494. doi: 10.18502/ijph.v52i7.13251. Iran J Public Health. 2023. PMID: 37593509 Free PMC article.
-
Effects of polygonum cuspidatum containing resveratrol on inflammation in male professional basketball players.Int J Prev Med. 2013 Apr;4(Suppl 1):S1-4. Int J Prev Med. 2013. PMID: 23717757 Free PMC article.
-
Potential protective mechanisms of aryl hydrocarbon receptor (AHR) signaling in benign prostatic hyperplasia.Differentiation. 2011 Nov-Dec;82(4-5):211-9. doi: 10.1016/j.diff.2011.05.011. Differentiation. 2011. PMID: 21684673 Free PMC article. Review.
References
-
- Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int. 2007;100(2):327–31. - PubMed
-
- Sauver JL, St, Jacobson DJ, McGree ME, Lieber MM, Jacobsen SJ. Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia. Am J Epidemiol. 2006;164(8):760–8. - PubMed
-
- Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, et al. Incidence and prevalence of lower urinary tract symp-toms suggestive of benign prostatic hyperplasia in primary care; the Triumph project. Eur Urol. 2002;42(4):323–8. - PubMed
-
- Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol. 2003;44(5):539–45. - PubMed
-
- Nickel JC. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis. Curr Opin Urol. 2006;16(1):5–10. - PubMed
LinkOut - more resources
Full Text Sources